SearchDictionaryMobileLogin

Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression.

AuthorsKadri Altundag, Mehmet E Tezcan, Mehmet Ozen, Fatih Karaahmet, Nilufer Bulut
JournalMedical hypotheses (Med Hypotheses) Vol. 68 Issue 1 Pg. 235 ( 2007) ISSN: 0306-9877 Scotland
PMID16905272 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • trastuzumab
  • Receptor, erbB-2
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • Breast (drug effects, metabolism)
  • Breast Neoplasms (drug therapy, metabolism)
  • Carcinoma, Ductal (drug therapy, metabolism)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Injections, Intralesional
  • Receptor, erbB-2 (antagonists & inhibitors, metabolism)